Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to identify and quantify circulating tumor markers, which are associated with the presence of tumors. The current imaging available does not allow specificity of tumor size as it relates to pseudoprogression (a temporary enlargement or "swelling" of the tumor after treatment before it shrinks). Our hope is that CTCs will provide a more accurate description of tumor state for high grade glioma patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02558335
Study type Observational
Source Abramson Cancer Center of the University of Pennsylvania
Contact
Status Completed
Phase
Start date April 2013
Completion date April 2020